BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6324820)

  • 1. Studies on the release of proteolytic enzymes during synovium-induced cartilage breakdown in vitro and the actions of anti-inflammatory drugs.
    Crossley MJ; Hunneyball IM
    Biochem Pharmacol; 1984 Apr; 33(8):1263-71. PubMed ID: 6324820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological studies on synovium-cartilage interactions in organ culture.
    Crossley MJ; Hunneyball IM
    Eur J Rheumatol Inflamm; 1982; 5(1):15-29. PubMed ID: 7044793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradative enzyme systems in cartilage.
    Ehrlich MG; Armstrong AL; Treadwell BV; Mankin HJ
    Clin Orthop Relat Res; 1986 Dec; (213):62-8. PubMed ID: 3022974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
    Shinmei M; Kikuchi T; Masuda K; Shimomura Y
    Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage explants from the joints of rabbits with a proliferative arthritis.
    Cambray GJ; Murphy G; Reynolds JJ
    Rheumatol Int; 1981; 1(2):69-72. PubMed ID: 6287561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destruction of articular cartilage by arthritic synovium in vitro: mechanism of breakdown and effect of indomethacin and prednisolone.
    Panagides J; Landes MJ; Sloboda AE
    Agents Actions; 1980 Apr; 10(1 Pt 2):22-30. PubMed ID: 6992543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage.
    Vignon E; Mathieu P; Louisot P; Richard M
    Arthritis Rheum; 1991 Oct; 34(10):1332-5. PubMed ID: 1657006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Rheumatol; 1988 Aug; 15(8):1198-204. PubMed ID: 3054093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of retinol and dexamethasone on cytokine-mediated control of metalloproteinases and their inhibitors by human articular chondrocytes and synovial cells in culture.
    McGuire-Goldring MK; Murphy G; Gowen M; Meats JE; Ebsworth NM; Poll C; Reynolds JJ; Russell RG
    Biochim Biophys Acta; 1983 Sep; 763(2):129-39. PubMed ID: 6311283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradative enzyme systems in osteoarthritic cartilage.
    Ehrlich MG
    J Orthop Res; 1985; 3(2):170-84. PubMed ID: 2987465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase A2 activity in human osteoarthritic cartilage.
    Vignon E; Mathieu P; Louisot P; Vilamitjana J; Harmand MF; Richard M
    J Rheumatol Suppl; 1989 Aug; 18():35-8. PubMed ID: 2553968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutral proteases in human osteoarthritic synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    Arthritis Rheum; 1986 Sep; 29(9):1112-21. PubMed ID: 3019359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tissue-culture model of cartilage breakdown in rheumatoid arthritis. Quantitative aspects of proteoglycan release.
    Steinberg J; Sledge CB; Noble J; Stirrat CR
    Biochem J; 1979 May; 180(2):403-12. PubMed ID: 486116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral proteases in human osteoarthritic synovium: quantification and characterization.
    Martel-Pelletier J; Pelletier JP
    J Rheumatol; 1987 May; 14 Spec No():38-40. PubMed ID: 3305937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture.
    Murphy G; McGuire MB; Russell RG; Reynolds JJ
    Clin Sci (Lond); 1981 Dec; 61(6):711-6. PubMed ID: 6271450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
    DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
    Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.
    Gowen M; Wood DD; Ihrie EJ; Meats JE; Russell RG
    Biochim Biophys Acta; 1984 Feb; 797(2):186-93. PubMed ID: 6320902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium in vitro. The effect of glucocorticoids and protein synthesis inhibitors.
    Klämfeldt A; Jones IL; McGuire MB
    Scand J Rheumatol; 1982; 11(4):230-4. PubMed ID: 7178859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selected antirheumatic drugs on the metabolism of cartilage and synovial tissue in experimental arthropathy.
    Skrivánková B; Podrazký V; Trnavský K; Julis I
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):523-8. PubMed ID: 1659645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral proteinases from articular chondrocytes in culture. 2. Metal-dependent latent neutral proteoglycanase, and inhibitory activity.
    Sapolsky AI; Malemud CJ; Norby DP; Moskowitz RW; Matsuta K; Howell DS
    Biochim Biophys Acta; 1981 Mar; 658(1):138-47. PubMed ID: 6783102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.